2 June 2023

Last updated: Monday 29 May 2023

Clinical trials

Development timelines for new oncology drugs

Destiny Pharma advances strategy against bacteria

FDA guides on accelerated approvals in oncology

Checkpoint inhibitors are focus at ESMO

Viable malaria vaccine moves a step closer

EU revamps regulation of clinical trials

Idiopathic Pulmonary Fibrosis: Surprise finding in the clinic

The RECOVERY trial - what has been achieved so far?

Novel antifungals set for market introduction

ASCO 2021- Oncology developers disclose their latest data